Market closedNon-fractional

Omega Therapeutics/OMGA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Omega Therapeutics

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.

Ticker

OMGA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Cambridge, United States

Employees

94

OMGA Metrics

BasicAdvanced
$104M
Market cap
-
P/E ratio
-$1.67
EPS
1.99
Beta
-
Dividend rate
$104M
1.99
2.872
2.481
269.928
308.592
-52.40%
-34.89%
-112.29%
21.106
2.53
2.53
-1.326
112.75%
-24.59%
-43.39%

What the Analysts think about OMGA

Analyst Ratings

Majority rating from 6 analysts.
Buy

OMGA Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-873.91% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.3M
155.56%
Net income
-$20M
-0.50%
Profit margin
-873.91%
-61.06%

OMGA Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 8.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.54
-$0.40
-$0.37
-$0.36
-
Expected
-$0.51
-$0.53
-$0.45
-$0.33
-$0.36
Surprise
6.48%
-24.32%
-17.50%
8.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Omega Therapeutics stock?

Omega Therapeutics (OMGA) has a market cap of $104M as of July 06, 2024.

What is the P/E ratio for Omega Therapeutics stock?

The price to earnings (P/E) ratio for Omega Therapeutics (OMGA) stock is 0 as of July 06, 2024.

Does Omega Therapeutics stock pay dividends?

No, Omega Therapeutics (OMGA) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Omega Therapeutics dividend payment date?

Omega Therapeutics (OMGA) stock does not pay dividends to its shareholders.

What is the beta indicator for Omega Therapeutics?

Omega Therapeutics (OMGA) has a beta rating of 1.99. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Omega Therapeutics stock

Buy or sell Omega Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing